Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
eXp World Holdings ( (EXPI) ) has provided an announcement.
On July 31, 2025, eXp World Holdings announced its Q2 2025 financial results, highlighting a 1% revenue increase to $1.3 billion and a net loss of $2.3 million. Despite a decrease in agents and real estate transactions, the company maintained strong agent satisfaction and expanded its global reach. The Board declared a $0.05 per share cash dividend for Q3 2025, reflecting continued shareholder returns.
The most recent analyst rating on (EXPI) stock is a Buy with a $10.75 price target. To see the full list of analyst forecasts on eXp World Holdings stock, see the EXPI Stock Forecast page.
Spark’s Take on EXPI Stock
According to Spark, TipRanks’ AI Analyst, EXPI is a Neutral.
eXp World Holdings shows robust revenue growth and a stable balance sheet, but faces challenges with profitability and recent free cash flow declines. Technical analysis indicates a bearish trend, while valuation concerns persist due to negative earnings. The earnings call provided a positive outlook due to international expansion and improved productivity, balancing some of the financial concerns.
To see Spark’s full report on EXPI stock, click here.
More about eXp World Holdings
eXp World Holdings, Inc. is the holding company for eXp Realty and SUCCESS Enterprises. eXp Realty is the largest independent real estate brokerage globally, operating as a cloud-based, agent-centric platform with over 82,000 agents in 28 countries, offering industry-leading commission splits, revenue share, and equity ownership opportunities. SUCCESS Enterprises, known for SUCCESS magazine, provides personal and professional development resources within the eXp ecosystem.
Average Trading Volume: 1,187,114
Technical Sentiment Signal: Hold
Current Market Cap: $1.75B
See more data about EXPI stock on TipRanks’ Stock Analysis page.